You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》传瑞信、中金及高盛加入微医上市团队 料上半年在港上市筹20-30亿美元
阿思达克 03-02 15:50
据路透旗下IFR报道,腾讯(00700.HK)有份投资的微医据今年在港上市,筹20-30亿美元,消息人士指公司计划将瑞信、中金及高盛加入其团队,并与招银国际、花旗及摩通合作,料交易最快今年上半年完成。

据悉微医寻求估值达150亿美元,受惠疫情带动需求,公司去年收入增长三倍,而逾半收入是订阅形式,其数码化长期病管理服务人均收入高达3,600元人民币,去年订户人数已达13.5万人。报道指公司寻求上市前估值达120亿美元,而上市後估值则达150亿美元,并将发售15-20%的股权。(el/k) ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account